A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization.
The purpose of this study is to learn if apixaban can prevent blood clots in the leg (deep vein thrombosis [DVT]) and lung (pulmonary embolism [PE]) that sometimes occur within patients hospitalized for acute medical illness, and to learn how apixaban compares to enoxaparin (Lovenox®) for preventing these clots. The safety of apixaban will also be studied.
Inclusion Criteria:
Exclusion Criteria:
Los Angeles, California 90033, United States
Shreveport, Louisiana 71103, United States
Detriot, Michigan 48202, United States
Mornstown, New Jersey 07962, United States
Buenos Aires, Buenos Aires C1181ACH, Argentina
Ciudad Autonoma Buenos Aires, Buenos Aires C1280AEB, Argentina
Derqui-Pilar, Buenos Aires B1629ODT, Argentina
Rancagua, Valparaiso, Chile
Arhus C, 8000, Denmark
Karlsbad, 76307, Germany
Hyderabad, Andhra Pradesh 500004, India
Ahemdabad, Gujarat 380054, India
Yung-Kang City, Tainan 710, Taiwan